Service and transaction scope
Banks Instruments coordinates preliminary review, authentication, underwriting submissions and closing requirements. The funding decision, pricing and proceeds are established only by the approved funding counterparty in writing.
Availability and indicative minimum
Eligible instruments may be considered under recourse or non-recourse structures. Banks Instruments does not charge an upfront monetization fee before conditional acceptance; any provider, banking, legal, custody or escrow cost must be disclosed separately in writing.
The instrument-specific minimum applies. Funding value, LTV, reserves and tranche size are determined only after authentication and underwriting.
Indicative programme threshold only. Availability, range, pricing, issuer, delivery route and eligibility are confirmed exclusively through due diligence and definitive written terms.
Indicative commercial assumptions
Fees and costs are scope-specific and depend on the appointed professionals and third parties involved. Any charge is disclosed in writing before substantive work begins.
Planning information only. It is not an offer, commitment, approval, guarantee or confirmation of availability.
Potential applications
- Illustrative recourse scenarios up to approximately 80% LTV
- Illustrative non-recourse scenarios up to approximately 65% LTV
- Indicative recourse cost assumptions from approximately 2%, where available
- Staged or single disbursement subject to definitive terms
Process
- Compliance and authority review
- Instrument, title, issuer and custody verification
- Receiving-bank or funding-counterparty readiness
- Indicative recourse or non-recourse offer
- Definitive loan and security documents
- SWIFT, Euroclear, DTCC or Bloomberg-supported transaction workflow where accepted
- Authentication and closing
- Single or staged disbursement under the executed agreement
Monetization options
- Recourse loan: up to approximately 80% LTV, indicative interest from approximately 2% per year and a term of up to 10 years, subject to underwriting
- Non-recourse loan: up to approximately 65% LTV with no general repayment obligation beyond the agreed assets and proceeds, subject to representations, exclusions and definitive terms
- Disbursement may be a single closing payment or documented tranches linked to authenticated acceptance and milestones
- Illustrative Banks Instruments success compensation is 5% of funds successfully disbursed, payable only upon completion under the executed engagement. Third-party banking, legal, custody or escrow costs are disclosed separately in writing.
- Illustrative example: an authenticated instrument with a face value of USD 100 million could be reviewed for gross recourse proceeds up to USD 80 million or gross non-recourse proceeds up to USD 65 million. These figures precede interest, reserves, success compensation and disclosed third-party costs and are not an offer or approval.
Illustrative recourse scenarios may reach approximately 80% LTV and non-recourse scenarios approximately 65% LTV. The approved funder determines actual value, pricing, reserves and conditions.
Requirements
- Instrument authenticity and ownership
- Issuer, custodian and delivery route
- Receiving-bank or funder acceptance
- Value, validity, encumbrances and restrictions
- KYC, KYB, source of wealth and source of funds
- Reserves, fees, recourse and closing conditions
Transaction protections
- Bank-compatible or bank-acknowledged wording only when expressly accepted by the participating institution
- A mutual 2% non-performance remedy only when negotiated, supported and written into the executed agreement
- Attorney trust or escrow controls only through a specifically appointed and independently verified professional
- Institution-to-institution authentication and written release conditions before value moves
Protections apply only when expressly incorporated into executed transaction documents and accepted by the relevant bank, provider, funder or appointed professional. They are not website guarantees.
Delivery and acceptance
All figures are scenario assumptions. No LTV, cost, funding amount or closing date is guaranteed.
Availability, price, timing and outcome remain subject to due diligence, counterparty approval and definitive executed agreements.
